Diabetologia

, Volume 22, Issue 3, pp 217–219 | Cite as

Branched-chain amino acids and alanine as indices of the metabolic control in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients

  • P. Vannini
  • G. Marchesini
  • G. Forlani
  • A. Angiolini
  • A. Ciavarella
  • M. Zoli
  • E. Pisi
Short Communications

Summary

Alterations in plasma branched-chain amino acids (valine, isoleucine and leucine) and alanine have been described in patients with insulin-dependent diabetes mellitus who have poor metabolic control. To assess the relevance of these abnormalities as indices of metabolic control, we sequentially evaluated plasma amino acids in 14 poorly controlled diabetics (seven Type 1 (insulin-dependent) and seven Type 2 (non-insulin-dependent) patients) until good control was achieved. The sum of branched-chain amino acids in both groups of uncontrolled diabetic patients was significantly increased compared with the values for the same subjects in good metabolic control. No statistically significant differences were present between ketotic and non-ketotic uncontrolled patients. The amelioration of the diabetic state with either insulin treatment or oral hypoglycaemic agents, reduced progressively branched-chain amino acids. The sum of valine, isoleucine and leucine strictly correlated with daily urinary glucose (r=0.73), but less well with fasting blood glucose (r=0.43), nonesterified fatty acids (r=0.46) and glycosylated haemoglobin (r=0.38). Alanine did not show any statistically significant differences at various stages of diabetic control. Branched-chain amino acids, but not alanine, may be used as indices of short-term diabetic control.

Key words

Branched-chain amino acids alanine diabetes isoleucine leucine valine 

References

  1. 1.
    Carlsten A, Hallgren B, Jagenbuerg R, Svanborg A, Werko L (1966) Amino acids and free fatty acids in plasma in diabetes. Acta Med Scand 170: 361–369Google Scholar
  2. 2.
    Felig P, Marliss E, Ohman J, Cahill GF (1970) Plasma amino acids in diabetic ketoacidosis. Diabetes 19: 727–729Google Scholar
  3. 3.
    Berger M, Zimmerman TH, Bertold P, Drost H, Muller WA, Gries FA, Zimmerman H (1978) Blood amino acids levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism 27: 793–799Google Scholar
  4. 4.
    Hanna AK, Zinman B, Nakhoda AF, Minuk HL, Stokes EF, Albisser AM, Leibel BS, Marliss EB (1980) Insulin, glucagon and amino acids during glycaemic control by the artificial pancreas in diabetic man. Metabolism 29: 321–332Google Scholar
  5. 5.
    Tamborlane WV, Sherwin RS, Genel M, Felig P (1979) Restoration of normal lipid and amino acid metabolism in diabetic patients treated with a portable insulin infusion pump. Lancet 1: 1258–1261Google Scholar
  6. 6.
    Pickup JC, Keen H, Parsons JA, Alberti KGMM, Rowe AS (1979) Continuous subcutaneous insulin infusion: improved blood glucose and intermediary metabolite control in diabetics. Lancet 1: 1255–1257Google Scholar
  7. 7.
    Marchesini G, Forlani G, Angiolini A, Scolari MP, Zoli M, Bianchi FB, Pisi E (1979) Oral glucose in cirrhotics. Effect on plasma aminoacid patterns and the role of insulin and glucagon. Diabète Metab 5: 135–139Google Scholar
  8. 8.
    Marchesini G, Forlani G, Zoli M, Angiolini A, Scolari MP, Bianchi FB, Pisi E (1979) Insulin and glucagon levels in liver cirrhosis: relationship with plasma amino acid imbalance of chronic hepatic encephalopathy. Dig Dis Sci 24: 594–601Google Scholar
  9. 9.
    Buse MG, Biggers JF, Friderici KIT (1972) Oxidation of branched-chain amino acids by isolated hearts and diaphragms of the rat. J Biol Chem 247: 8085–8096Google Scholar
  10. 10.
    Goldberg AL, Odessey R (1972) Oxidation of amino acids by diaphragms from fed and fasted rats. Am J Physiol 223: 1384–1391Google Scholar
  11. 11.
    Wahren J, Felig P, Hagenfeldt J (1976) Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest 57: 987–999Google Scholar
  12. 12.
    Felig P, Wahren J, Sherwin R, Palaiologos G (1977) Amino acid and protein metabolism in diabetes mellitus. Arch Intern Med 137: 507–513Google Scholar
  13. 13.
    Felig P, Marliss E, Cahill GF (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281: 811–815Google Scholar
  14. 14.
    Sherwin RS, Fischer M, Hendler R, Felig P (1976) Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med 294: 455–461Google Scholar
  15. 15.
    Sherwin R, Hendler R, Felig P (1975) Effects of ketone administration on amino acid metabolism in man. J Clin Invest 55: 1382–1390Google Scholar
  16. 16.
    Sherwin R, Hendler R, Felig P (1976) Effects of diabetes mellitus and insulin on the turnover and metabolic response to ketones in man. Diabetes 25: 776–784Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • P. Vannini
    • 1
  • G. Marchesini
    • 2
  • G. Forlani
    • 1
  • A. Angiolini
    • 2
  • A. Ciavarella
    • 1
  • M. Zoli
    • 2
  • E. Pisi
    • 2
  1. 1.Cattedra e Servizio di Malattie del RicambioUniversità di BolognaBolognaItaly
  2. 2.Istituto di Patologia Medica 1Università di BolognaBolognaItaly

Personalised recommendations